Skip to main content
Neuland Laboratories Limited. logo

Neuland Laboratories Limited. — Investor Relations & Filings

Ticker · NEULANDLAB ISIN · INE794A01010 LEI · 335800AVHZURTYQ17N08 BSE.NS Manufacturing
Open in API
Filings indexed 943 across all filing types
Latest filing 2026-03-11 Regulatory Filings
Country IN India
Listing BSE.NS NEULANDLAB

About Neuland Laboratories Limited.

https://www.neulandlabs.com

Neuland Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and provides comprehensive Custom Manufacturing Solutions (CMS). The company focuses on complex chemistry and high-quality standards, operating state-of-the-art manufacturing facilities that comply with international regulatory requirements, including those of the USFDA and EDQM. Its product portfolio spans diverse therapeutic areas such as cardiovascular, central nervous system, anti-infectives, and antiasthmatics. Neuland supports pharmaceutical companies globally through the entire lifecycle of a drug, from early-stage clinical development to commercial-scale production. By leveraging advanced technical expertise and a robust quality management system, the organization delivers reliable chemical synthesis and process optimization services to both innovator and generic drug manufacturers.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE Limited and NSE India) regarding a newspaper advertisement about a Special Window for transfer and dematerialization of physical shares. It references compliance with SEBI regulations and circulars. The content is an announcement of a newspaper advertisement and does not contain financial statements, management discussion, or detailed financial data. The document length is 15,000 characters, but the content is primarily an announcement for regulatory compliance purposes. There is no indication of it being a financial report, earnings release, or management report. It fits best as a Regulatory Filing (RNS) because it is a regulatory announcement that does not fit other specific categories.
2026-03-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about the schedule of upcoming analyst and institutional investor meetings. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is about notifying the schedule of investor meetings, not about financial results, reports, or any other filings. The document length is short (1616 characters), and it is an announcement of meetings rather than a report or detailed financial disclosure. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-03-03 English
Demise
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to stock exchanges regarding the sad demise of a Non-Executive Non-Independent Director of the company. It references Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements, which pertains to disclosures about changes in the board of directors. The content focuses on informing about the cessation of a director due to death, including details such as DIN, date of cessation, and related regulatory references. There are no financial statements, earnings data, or report attachments. The document is clearly an announcement of a board/management change rather than a full report or other filing type.
2026-03-03 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call for Neuland Laboratories Limited, covering the quarter and nine months ended December 31, 2025. It includes management commentary on financial results, business trends, and a Q&A session with analysts. The presence of detailed financial figures, discussion of margins, revenues, and operational details confirms this is a full earnings call transcript rather than a brief earnings release or summary. The document also references the call date and the fiscal period clearly, and the content matches the typical structure of an earnings call transcript with management remarks and Q&A. Therefore, the appropriate classification is Call Transcript (CT).
2026-02-13 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges and the company secretary regarding the re-lodgement of transfer requests of physical shares, pursuant to a SEBI circular. It contains no financial statements, no management discussion, no earnings data, no audit information, and no report attachments. The content is an update or notification about share transfer requests processing status, which is regulatory in nature but does not fit into categories like Annual Report, Earnings Release, or Capital Update. The document is short (2517 characters) and serves as an official communication to stock exchanges and the company secretary for information and records. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2026-02-11 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE Limited and NSE India) regarding the publication of newspaper advertisements about the company's financial results for the quarter and nine months ended December 31, 2025. It references Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, which mandates disclosure of financial results via advertisements. The document does not contain the financial results themselves but encloses copies of newspaper advertisements. The length is about 15,000 characters, but the content is primarily an announcement of the publication of financial results, not the results report itself. Therefore, this is an announcement related to the publication of a financial report, not the report itself. According to the "Menu vs Meal" rule, such documents are classified as Report Publication Announcement (RPA).
2026-02-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.